Clemson vs. Boston University: Which Is Better for Biomedical Engineering?

For biomedical engineering specifically, Boston University is the more compelling choice for most students, particularly those seeking clinical exposure, medical-device research, and biotech internships during the academic year. BU offers an ABET-accredited biomedical engineering degree within its College of Engineering and places students in the middle of Boston’s unusually dense hospital, research, and life-sciences ecosystem. Clemson also has an ABET-accredited B.S. in Bioengineering, but its setting is less connected to a major biomedical industry hub.

BU’s location is its clearest advantage. Students can pursue research, co-ops, and internships with nearby hospitals, university labs, startups, and established biotech and medical-device organizations. That proximity can make it easier to test different BME paths, such as imaging, biomaterials, rehabilitation technology, or translational research.

Clemson offers a more traditional campus experience, strong engineering culture, and meaningful bioengineering opportunities, including work connected to health sciences and research initiatives. Its program can be especially attractive for a student who prefers a large public-university environment, campus community, and potentially lower cost, particularly with South Carolina in-state tuition.

The financial difference deserves serious weight: a substantially lower Clemson net price can outweigh BU’s location advantage, especially if graduate school, medical school, or other professional training is part of the plan. Otherwise, BU provides the more direct launch point into the biomedical engineering field.